Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorKibirige, Davis
dc.contributor.authorKampiire, Leaticia
dc.contributor.authorAtuhe, David
dc.contributor.authorMwebaze, Raymond
dc.contributor.authorKatagira, Winceslaus
dc.contributor.authorMuttamba, Winters
dc.contributor.authorNantanda, Rebecca
dc.contributor.authorWorodria, William
dc.contributor.authorKirenga, Bruce
dc.date.accessioned2021-03-24T13:30:10Z
dc.date.available2021-03-24T13:30:10Z
dc.date.issued2017-12-08
dc.identifier.citationKibirige , D , Kampiire , L , Atuhe , D , Mwebaze , R , Katagira , W , Muttamba , W , Nantanda , R , Worodria , W & Kirenga , B 2017 , ' Access to affordable medicines and diagnostic tests for asthma and COPD in sub Saharan Africa : the Ugandan perspective ' , BMC Pulmonary Medicine , vol. 17 , 179 . https://doi.org/10.1186/s12890-017-0527-yen
dc.identifier.issn1471-2466
dc.identifier.otherPURE: 273006792
dc.identifier.otherPURE UUID: 4d03c981-564d-46f0-8a1c-737c25c58ef7
dc.identifier.otherPubMed: 29216852
dc.identifier.otherPubMedCentral: PMC5721472
dc.identifier.otherScopus: 85043987363
dc.identifier.otherORCID: /0000-0001-7154-2964/work/89628350
dc.identifier.urihttps://hdl.handle.net/10023/21704
dc.descriptionFunding: This study was supported by a small grant from Uganda Diabetes Association, a diabetes professional association for diabetic patients and healthcare practitioners.en
dc.description.abstractBackground: Equitable access to affordable medicines and diagnostic tests is an integral component of optimal clinical care of patients with asthma and chronic obstructive pulmonary disease (COPD). In Uganda, we lack contemporary data about the availability, cost and affordability of medicines and diagnostic tests essential in asthma and COPD management. Methods: Data on the availability, cost and affordability of 17 medicines and 2 diagnostic tests essential in asthma and COPD management were collected from 22 public hospitals, 23 private and 85 private pharmacies. The percentage of the available medicines and diagnostic tests, the median retail price of the lowest priced generic brand and affordability in terms of the number of days' wages it would cost the least paid public servant were analysed. Results: The availability of inhaled short acting beta agonists (SABA), oral leukotriene receptor antagonists (LTRA), inhaled LABA-ICS combinations and inhaled corticosteroids (ICS) in all the study sites was 75%, 60.8%, 46.9% and 45.4% respectively. None of the study sites had inhaled long acting anti muscarinic agents (LAMA) and inhaled long acting beta agonist (LABA)-LAMA combinations. Spirometry and peak flow-metry as diagnostic tests were available in 24.4% and 6.7% of the study sites respectively. Affordability ranged from 2.2 days' wages for inhaled salbutamol to 17.1 days' wages for formoterol/budesonide inhalers and 27.8 days' wages for spirometry. Conclusion: Medicines and diagnostic tests essential in asthma and COPD care are not widely available in Uganda and remain largely unaffordable. Strategies to improve access to affordable asthma and COPD medicines and diagnostic tests should be implemented in Uganda.
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofBMC Pulmonary Medicineen
dc.rightsCopyright © The Author(s). 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en
dc.subjectAdministration, inhalationen
dc.subjectAdrenal cortex hormones/economicsen
dc.subjectAdrenergic beta-agonists/economicsen
dc.subjectAlbuterol/economicsen
dc.subjectAnti-asthmatic agents/supply & distributionen
dc.subjectAsthma/diagnosisen
dc.subjectBudesonide, Formoterol Fumarate drug combination/economicsen
dc.subjectDiagnostic techniques, respiratory system/statistics & numerical dataen
dc.subjectDrug combinationsen
dc.subjectDrug costsen
dc.subjectFluticasone-Salmeterol drug combination/economicsen
dc.subjectHealth services accessibilityen
dc.subjectHumansen
dc.subjectLeukotriene antagonists/economicsen
dc.subjectMuscarinic antagonists/economicsen
dc.subjectPulmonary disease, chronic obstructive/diagnosisen
dc.subjectRespiratory function testsen
dc.subjectSpirometryen
dc.subjectUgandaen
dc.subjectRA0421 Public health. Hygiene. Preventive Medicineen
dc.subjectRM Therapeutics. Pharmacologyen
dc.subject3rd-DASen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subject.lccRA0421en
dc.subject.lccRMen
dc.titleAccess to affordable medicines and diagnostic tests for asthma and COPD in sub Saharan Africa : the Ugandan perspectiveen
dc.typeJournal articleen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.contributor.institutionUniversity of St Andrews. Infection and Global Health Divisionen
dc.identifier.doihttps://doi.org/10.1186/s12890-017-0527-y
dc.description.statusPeer revieweden


This item appears in the following Collection(s)

Show simple item record